Accenture CEO Julie Sweet buys 5,172 shares in equity plan

Accenture plc reported that its Chair and CEO, Julie Spellman Sweet, who is also a director, acquired additional company stock.

Rhea-AI Filing Summary

Accenture plc reported that its Chair and CEO, Julie Spellman Sweet, who is also a director, acquired additional company stock. On 12/05/2025, she purchased 5,172 Class A ordinary shares of Accenture at a price of $268.535 per share through the Accenture Voluntary Equity Investment Program. Following this transaction, she beneficially owns 14,113 Class A ordinary shares, held directly.

Insider Trade Summary

Grant/Award: 5,172 shares

Grant/Award 1 txn

Insider Sweet Julie Spellman

Role Chair and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	5,172	$268.535	$1.39M

Holdings After Transaction: Class A ordinary shares — 14,113 shares (Direct)

Footnotes (1)

1. F1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Accenture (ACN) disclose in this Form 4?

Accenture disclosed that Chair and CEO Julie Spellman Sweet acquired 5,172 Class A ordinary shares of Accenture plc on 12/05/2025.

At what price did Julie Sweet buy Accenture (ACN) shares?

Julie Sweet purchased the Accenture Class A ordinary shares at a price of $268.535 per share.

How many Accenture (ACN) shares does Julie Sweet own after this transaction?

After the reported purchase, Julie Sweet beneficially owns 14,113 Class A ordinary shares of Accenture plc, held directly.

What program was used for Julie Sweet’s Accenture (ACN) share purchase?

The filing states that the shares were purchased from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

What is Julie Sweet’s role at Accenture (ACN) according to this filing?

Julie Spellman Sweet is identified as both a Director and an Officer, serving as Chair and CEO of Accenture plc.

Is this Accenture (ACN) Form 4 filed for one reporting person or multiple?

The Form 4 is indicated as being filed by one reporting person, referring to Julie Spellman Sweet.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 04:14 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweet Julie Spellman

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	12/05/2025		A		5,172(1)	A	$268.535	14,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.